Fiche publication


Date publication

septembre 2016

Journal

Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique

Auteurs

Membres identifiés du Cancéropôle Est :
Pr PEIFFERT Didier


Tous les auteurs :
Rio E, Mornex F, Peiffert D, Huertas A

Résumé

Recent technological developments led to develop the concept of focused liver radiation therapy. We must distinguish primary and secondary tumors as the indications are restricted and must be discussed as an alternative to surgical or medical treatments. For hepatocellular carcinoma 5 to 10cm (or more), a conformational radiation with or without intensity modulation is performed. Stereotactic body radiotherapy (SBRT) is being evaluated and is increasingly proposed as an alternative to radiofrequency ablative treatment for primary or secondary tumors (typically less than 5cm). Tumor (and liver) movements induced by respiratory motions must be taken into account. Strict dosimetric criteria must be met with particular attention to the dose-volume histograms to liver and the hollow organs, including cases of SBRT.

Mots clés

Carcinoma, Hepatocellular, radiotherapy, Combined Modality Therapy, Dose Fractionation, Humans, Liver Neoplasms, radiotherapy, Organs at Risk, Palliative Care, methods, Radiation Injuries, prevention & control, Radiosurgery, adverse effects, Radiotherapy Dosage, Radiotherapy Planning, Computer-Assisted, Radiotherapy, Conformal, adverse effects, Radiotherapy, Image-Guided, methods

Référence

Cancer Radiother. 2016 Sep;20 Suppl:S174-8